A global economic analysis of HIV infection amongst people who inject drugs, finding that harm reduction interventions are not implemented to the level that their efficacy warrants, and that doing so at scale would be both cost effective and responsive to a human rights imperative.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.